Literature DB >> 2996445

Inhibitory effects of dapsone on enzymatic activities of membrane phospholipids in human blood cells.

Y Niwa, Y Miyachi.   

Abstract

In order to elucidate the action mechanism of dapsone on blood cell membranes, we assessed the dose-dependent effect of dapsone on the activities of choline phosphotransferase (which mediates the production of the structural phospholipid, phosphatidylcholine) and methyltransferase (which produces phosphatidylcholine from phosphatidylethanolamine, representing the dynamics of the cells) in the membranes of red cells, lymphocytes, and neutrophils obtained from 16 healthy human subjects. The methyltransferase activity of lymphocyte and neutrophil cell membranes was slightly inhibited by dapsone, although only at a high concentration (1 mM), while that of red cells was not affected. On the other hand, dapsone significantly decreased the choline-phosphotransferase activity of red-cell membranes in a dose-dependent fashion, but did not significantly inhibit that of lymphocytes or neutrophils. The mechanisms of the hemolytic side effect of dapsone on erythrocytes and its anti-inflammatory effect on neutrophils are discussed in connection with its inhibitory effect on the enzymatic activities of membrane phospholipids.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996445     DOI: 10.1007/bf00510065

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  28 in total

1.  Mode of coupling between hormone receptors and adenylate cyclase elucidated by modulation of membrane fluidity.

Authors:  G Rimon; E Hanski; S Braun; A Levitzki
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

2.  Effect of the lipid environment on protein motion and enzymatic activity of sarcoplasmic reticulum calcium ATPase.

Authors:  C Hidalgo; D D Thomas; N Ikemoto
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

3.  The haemolytic action of dapsone: changes in the red-cell membrane.

Authors:  M R Rasbridge; G L Scott
Journal:  Br J Haematol       Date:  1973-02       Impact factor: 6.998

4.  Chemoattractants stimulate degradation of methylated phospholipids and release of arachidonic acid in rabbit leukocytes.

Authors:  F Hirata; B A Corcoran; K Venkatasubramanian; E Schiffmann; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

5.  Phospholipid methylation unmasks cryptic beta-adrenergic receptors in rat reticulocytes.

Authors:  W J Strittmatter; F Hirata; J Axelrod
Journal:  Science       Date:  1979-06-15       Impact factor: 47.728

6.  Role of stimulated neutrophils from patients with systemic lupus erythematosus in disturbed immunoreactivity, with special reference to increased oxygen intermediates generated by the neutrophils.

Authors:  Y Niwa; T Sakane; M Shingu; M Yokoyama
Journal:  J Clin Lab Immunol       Date:  1984-05

7.  Phospholipid methylation: a biochemical signal modulating lymphocyte mitogenesis.

Authors:  F Hirata; S Toyoshima; J Axelrod; M J Waxdal
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

Review 8.  Phospholipid methylation and biological signal transmission.

Authors:  F Hirata; J Axelrod
Journal:  Science       Date:  1980-09-05       Impact factor: 47.728

9.  Methyltransferase and phospholipase A2 activity in membranes of neutrophils and lymphocytes from patients with bacterial and viral infections.

Authors:  Y Niwa; T Sakane; S Yamamoto; T Kano; S Taniguchi
Journal:  Inflammation       Date:  1985-03       Impact factor: 4.092

10.  Phospholipid transmethylation in the membrane of human neutrophils and lymphocytes.

Authors:  Y Niwa; T Sakane; S Taniguchi
Journal:  Arch Biochem Biophys       Date:  1984-10       Impact factor: 4.013

View more
  1 in total

Review 1.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.